Patients with multiple myeloma receiving daratumumab have an increased risk for infections, yet listeriosis is an underrecognized complication. This case report details a patient who had Listeria monocytogenes meningoencephalitis after daratumumab therapy: bit.ly/44LETtd

Can mannitol reduce the risk of cisplatin-induced nephrotoxicity? This retrospective review explores outcomes in patients treated with or without mannitol from 2006–2012. Read the findings: bit.ly/4d73afw #Cisplatin #Nephrotoxicity #OncologyPharmacy

Have you checked out the new HOPA Corner on our website? Featuring interviews and information from HOPA, our latest post showcases a chat with HOPA's new president, Robert Mancini, as well as a recap of his address from HOPA's recent annual conference: bit.ly/4kR2n5G

In this article, the authors assess the efficacy and adverse events of 7+3 chemotherapy versus HMA+venetoclax in patients acute myeloid leukemia who are marginal candidates for either regimen. Read more: bit.ly/4k4Bt98 #Leukemia #LeukemiaTreatment #CancerResearch

If your ASCO withdrawal symptoms include craving more cutting-edge insights, there's a cure! Watch or listen to our exclusive interview series “Voices from ASCO: Conversations in Oncology,” featuring top experts: bit.ly/3ZZuZRF #ASCO25 #OncologyInnovation ASCO

❤️🤍💙Happy Fourth of July from JHOP!❤️🤍💙 Today we celebrate the values that unite us - freedom, resilience, and community. We also celebrate the medical professionals who bring these values to patients every day. Wishing you a safe and fun holiday! #4thOfJuly #JulyFourth

Our Voices from ASCO: Conversations in Oncology Spotlight of the Day is on Dr. Shanthi Sivendran - Senior VP of Cancer Care Support at American Cancer Society. She discusses ACS's patient support programs: bit.ly/3ZZuZRF #OncologyInnovations #FutureOfOncology #CancerCare

Our Voices from ASCO: Conversations in Oncology Spotlight is Dr. Greg Kalemkerian! Dr. Kalemkerian is a medical oncologist and professor at University of Michigan. Here, he provides insights into the evolving landscape of lung cancer treatment: bit.ly/3ZZuZRF #OncologyInnovations

Dr. Ghassan Abou-Alfa is a renowned medical oncologist at Memorial Sloan Kettering Cancer Center. Here, he discusses the impact of cholangiocarcinoma and the role of the CCA Summit in driving research, collaboration, and improved patient care: bit.ly/3ZZuZRF #OncologyInnovations #CancerCare

Headaches are a common side effect of complement inhibitors used to treat paroxysmal nocturnal hemoglobinuria. This article explores how to distinguish nitric oxide–related headaches from signs of meningitis: bit.ly/4lWkGGH #PNH #ComplementInhibitors #HeadacheManagement

Today’s #VoicesFromASCO spotlight is on Maimah Karmo, founder of Tigerlily Foundation and a 20-year triple-negative breast cancer survivor. Hear her inspiring journey and how Tigerlily empowers women fighting breast cancer. Watch/listen: bit.ly/3ZZuZRF #CancerCare #Oncology

This case study highlights a 63-year-old with signet ring cell breast carcinoma only in her bones—the 2nd known case—and the first documented treatment regimen of ribociclib, fulvestrant & denosumab: bit.ly/45d5u0O #BreastCancer #RareCancer #CaseStudy #CancerResearch

A patient with severe aplastic anemia was treated with eATG and developed life-threatening serum sickness, unresponsive to standard care. In a groundbreaking approach, adding tocilizumab helped reverse symptoms: bit.ly/45tAjyK #AplasticAnemia #PharmacyInnovation

Rare but serious: A new case report details irinotecan-induced muscle cramping and hypertonia in a pancreatic cancer patient. Learn more about how to prevent treatment interruptions: bit.ly/3V0B4KF #Oncology #CancerTreatment #PancreaticCancer #ChemoSideEffects

Patients with multiple myeloma are 9x more likely to have venous thromboembolic events. This study evaluated if patients receiving immunomodulatory drugs were on appropriate anticoagulation based on SAVED score: bit.ly/45xmW1E #MultipleMyeloma #OncologyHematology

Looking for practical guidance for managing bispecific antibodies in the treatment of multiple myeloma? This article provides expert tips for dealing with patients who experience adverse events with treatment: bit.ly/3HWfCn7 #BispecificAntibodies #MultipleMyeloma

Check out the 11th Annual Patient Support Services Guide from our sister publication Oncology Practice Management. It's an excellent resource for your patients - providing essential information on financial assistance options: bit.ly/4l9ekUz #Oncology #Hematology #CancerTreatment

🩸 September is Blood Cancer Awareness Month! 🩸 Early detection, research, and treatment breakthroughs are making a difference every day. Check out this article on the transformative therapy of CAR T-cells: bit.ly/41RFCH7 #BloodCancerAwareness #HopeForACure

It's World Lymphoma Day! A day dedicated to raising awareness about lymphoma and supporting those impacted by this form of blood cancer. Education, early diagnosis, and supporting ongoing research are key to improving outcomes. #WorldLymphomaDay #LymphomaAwareness #BloodCancer

HSCT is a complication that increases the risk of morbidity and mortality. Could eltrombopag be the solution? This review of 67 patients sheds light on its potential as a treatment for post-HSCT thrombocytopenia: bit.ly/46sgsQZ #HSCT #Thrombocytopenia #Eltrombopag